Kansas college student wins appeal, insurance approves treatment
KSN TV
[{'start': '0.960', 'end': '5.040', 'text': 'Jasmine, thank you. An update tonight on'}, {'start': '2.960', 'end': '7.279', 'text': 'a story we first brought to you in March'}, {'start': '5.040', 'end': '9.519', 'text': 'about an Achinson College student denied'}, {'start': '7.279', 'end': '11.920', 'text': 'medicine she says was keeping her'}, {'start': '9.519', 'end': '14.320', 'text': "Crohn's disease in check for years. A"}, {'start': '11.920', 'end': '16.320', 'text': 'viewer reached out to KSN and donated a'}, {'start': '14.320', 'end': '18.960', 'text': 'month of treatment from their pharmacy'}, {'start': '16.320', 'end': '21.119', 'text': 'in Tennessee to her doctor in Kansas'}, {'start': '18.960', 'end': '23.760', 'text': 'City. At that point, Natalie Graves'}, {'start': '21.119', 'end': '25.600', 'text': 'filed an appeal and last week learned'}, {'start': '23.760', 'end': '28.000', 'text': 'Blue Cross and Blue Shield of Kansas'}, {'start': '25.600', 'end': '30.960', 'text': 'reversed the previous denial approving'}, {'start': '28.000', 'end': '33.520', 'text': 'her treatment until March of 2026. She'}, {'start': '30.960', 'end': '35.760', 'text': 'says she is shocked by how quick things'}, {'start': '33.520', 'end': '38.480', 'text': 'turned around in her favor. So'}, {'start': '35.760', 'end': '42.040', 'text': 'incredible that within 6 weeks of like a'}, {'start': '38.480', 'end': '46.160', 'text': 'post being posted in a news story that'}, {'start': '42.040', 'end': '48.640', 'text': 'um my like a 12 month battle was like'}, {'start': '46.160', 'end': '50.480', 'text': 'shortened and like ended just like that.'}, {'start': '48.640', 'end': '52.399', 'text': 'A statement from Blue Cross Blue Shield'}, {'start': '50.480', 'end': '54.320', 'text': 'of Kansas says in part, quote,'}, {'start': '52.399', 'end': '57.199', 'text': 'prescription drug costs are a main'}, {'start': '54.320', 'end': '59.600', 'text': 'driver of rising health care costs. Our'}, {'start': '57.199', 'end': '61.920', 'text': 'policy supports the use of bioimilar'}, {'start': '59.600', 'end': '63.840', 'text': 'drugs when possible as they are safe,'}, {'start': '61.920', 'end': '67.760', 'text': 'effective, and expected to have similar'}, {'start': '63.840', 'end': '67.760', 'text': 'results at a significantly lower'}]